Evidence map›Paper›PMID 27338793›Full record

ArticleNature2016

H4K20me0 marks post-replicative chromatin and recruits the TONSL–MMS22L DNA repair complex.

Giulia Saredi, Hongda Huang, Colin M Hammond, Constance Alabert, Simon Bekker-Jensen, Ignasi Forne, Nazaret Reverón-Gómez, Benjamin M Foster, Lucie Mlejnkova, Till Bartke and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 1 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 1 synthesis or guideline pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Giulia Saredi *Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Hongda Huang *Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.
Colin M HammondBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Constance AlabertBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Simon Bekker-JensenThe Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark.
Ignasi ForneDepartment of Molecular Biology, Biomedical Center and Center for Integrated Protein Science Munich, Ludwig-Maximilians University, Munich, Germany.
Nazaret Reverón-GómezBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Benjamin M FosterMRC Clinical Sciences Centre, Imperial College London, United Kingdom.
Lucie MlejnkovaInstitute of Molecular Cancer Research, University of Zurich, Switzerland.
Till BartkeMRC Clinical Sciences Centre, Imperial College London, United Kingdom.
Petr CejkaInstitute of Molecular Cancer Research, University of Zurich, Switzerland.
Niels MailandThe Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark.
Axel ImhofDepartment of Molecular Biology, Biomedical Center and Center for Integrated Protein Science Munich, Ludwig-Maximilians University, Munich, Germany.
Dinshaw J PatelStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.
Anja GrothBiotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
University of Copenhagen · DKImperial College London · GBMemorial Sloan Kettering Cancer Center · USUniversity of Zurich · CHCenter for Integrated Protein Science Munich · DELudwig-Maximilians-Universität München · DE

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
European Research Council 281765European Research Council 309952Medical Research Council MC_UP_1102/2NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

After DNA replication, chromosomal processes including DNA repair and transcription take place in the context of sister chromatids. While cell cycle regulation can guide these processes globally, mechanisms to distinguish pre- and post-replicative states locally remain unknown. Here we reveal that new histones incorporated during DNA replication provide a signature of post-replicative chromatin, read by the human TONSL–MMS22L homologous recombination complex. We identify the TONSL ankyrin repeat domain (ARD) as a reader of histone H4 tails unmethylated at K20 (H4K20me0), which are specific to new histones incorporated during DNA replication and mark post-replicative chromatin until the G2/M phase of the cell cycle. Accordingly, TONSL–MMS22L binds new histones H3–H4 both before and after incorporation into nucleosomes, remaining on replicated chromatin until late G2/M. H4K20me0 recognition is required for TONSL–MMS22L binding to chromatin and accumulation at challenged replication forks and DNA lesions. Consequently, TONSL ARD mutants are toxic, compromising genome stability, cell viability and resistance to replication stress. Together, these data reveal a histone-reader-based mechanism for recognizing the post-replicative state, offering a new angle to understand DNA repair with the potential for targeted cancer therapy.

Indexed as

DNA RepairDNA ReplicationChromatinDNA-Binding ProteinsGenomic InstabilityHistonesHomologous RecombinationHumansLysineMethylationModels, MolecularMolecular ChaperonesNF-kappa BNuclear ProteinsProtein BindingProtein Structure, TertiaryChromatinDNA-Binding ProteinsHistonesLysineMMS22L protein, humanMolecular ChaperonesNF-kappa BNuclear ProteinsTONSL protein, human

Identifiers

PMID27338793
PMCPMC4939875
OpenAlexW2473363865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.